Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasilisa Rudneva

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2019
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)Lucie Lafay-Cousin, Eric Bouffet, Douglas Strother, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa Rudneva, Adam Newton, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2019
Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221)Lucie Lafay-Cousin, Eric Bouffet, Douglas Strother, et al.
The Journal of Clinical Endocrinology and Metabolism|March 20, 2025
Immune checkpoint inhibitor therapy for aggressive pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa Rudneva, Adam Newton, et al.
Pageof 1